Article Text
Abstract
Radiation therapy is widely used for benign and malignant brain tumours as it is effective and well tolerated. However, damage to the surrounding healthy nervous system tissue leads to a variety of complications both in the short term and long term, ranging from mild and self-limiting to irreversible and fatal. Radiation neurotoxicity is due to a combination of early inflammation and oligodendroglial damage followed later by brain tissue necrosis, white matter damage, accelerated vascular disease and the development of secondary tumours. This article explains the basic principles of radiation physics, the different modalities used in clinical practice, how radiotherapy is planned and delivered and the scientific basis of radiation damage. The main body of the article focuses on the clinical features of radiation toxicity in the brain, spinal cord, cranial and peripheral nerves with an emphasis on the distinction between early and delayed complications.
- radiotherapy
- cerebrovascular disease
- clinical neurology
- cognition
- dementia
Data availability statement
No data are available.
Statistics from Altmetric.com
Data availability statement
No data are available.
Footnotes
Contributors MK contributed the section on Mechanisms of radiation damage, treatment planning and dose fractionation; JR designed the concept of the paper, wrote the section on radiation complications, key points, figures and legends and subsequent revisions.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Provenance and peer review. Commissioned. Externally peer reviewed by Robin Grant, Edinburgh, UK and Fiona McKevitt, Sheffield, UK.
Linked Articles
- Highlights from this issue
Read the full text or download the PDF:
Other content recommended for you
- Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes
- The neurofibromatoses
- Malignant peripheral nerve sheath tumour arising in the submandibular gland
- Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1
- Radiation-induced optic neuropathy: a review
- Malignant peripheral nerve sheath tumours in neurofibromatosis 1
- Neurofibromatosis type 2
- Neurofibromatosis type 1: from genotype to phenotype
- Neuro-oncology
- Neurofibromatosis type 1 mosaicism in patients with constitutional mismatch repair deficiency